Abstract:Recent work suggests that extracellular (cell-free) nucleic acids, both DNA and RNA species, as well as extracellular nucleosomes can activate blood coagulation and promote thrombosis in vitro and in vivo (1, 2). Indeed, they substantially contribute to the development of microvascular thrombosis which can act as an intravascular immune response to circulating bacteria and has been termed immunothrombosis (3). However, they also foster pathological vessel occlusions as shown in animal models of large vessel thrombosis including deep-vein thrombosis and arterial thrombosis. Large filaments of extracellular nucleosomes that are released from activated neutrophils (neutrophil extracellular traps, NETs) and isolated extracellular nucleosomes support fibrin formation and platelet adhesion/activation via different mechanisms. These include for example stimulation of fibrin formation by degradation of the endogenous anticoagulant tissue factor pathway inhibitor and via activation of proteins involved in the contact pathway of blood coagulation such as factor XII (2, 3). The study by Varju et al. (4) adds a new aspect to the procoagulant role of nucleosome components and NETs. These authors show that isolated eukaryotic DNA and histone proteins such as HIIIS enhance the diameter of thrombus-forming fibrin fibers under in vitro conditions. Moreover, they are found to decrease the permeability of fibrin clots and to enhance the overall stability of such clots. Mechanistically, these effects are mediated by regulation of endogenous anticoagulant and fibrinolytic pathways. Indeed, histone proteins prevented the inactivation of thrombin by antithrombin and DNA reduced plasminogen activation. Furthermore, NETs released from isolated neutrophils suppressed t-PA-promoted fibrinolysis. Together with earlier work, these results further corroborate the conclusion that extracellular nucleosomes and their major components target the coagulation system at different levels and that their overall effect is to enhance fibrin formation. It will be of interest to clarify in the future whether the stabilization of fibrin clots by histones, DNA and nucleosomes as shown in (4) contributes to the prothrombotic role of NETs and extracellular nucleosomes in vivo.

Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis

Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA

Involvement of peptidylarginine deiminase 4 in eosinophil extracellular trap formation and contribution to citrullinated histone signal in thrombi

Neutrophil extracellular traps promote fibrous vascular occlusions in chronic thrombosis

Deletion of pyruvate dehydrogenase kinases reduces susceptibility to deep vein thrombosis in mice

Extracellular DNA and histones as thrombus stabiliser

Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation

Mice with Reduced PAR4 Reactivity show Decreased Venous Thrombosis and Platelet Procoagulant Activity

Abstract 569: Neutrophil Extracellular Traps Promote Thrombin Generation Through Platelet-Dependent and -Independent Mechanisms

Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion

Neutrophil extracellular trap-microparticle complexes enhance thrombin generation via the intrinsic pathway of coagulation in mice

Platelet Factor 4 Promotes Deep Venous Thrombosis by Regulating the Formation of Neutrophil Extracellular Traps

Compromised Anti-inflammatory Action of Neutrophil Extracellular Traps in PAD4-Deficient Mice Contributes to Aggravated Acute Inflammation After Myocardial Infarction

Zinc-dependent histone deacetylases drive neutrophil extracellular trap formation and potentiate local and systemic inflammation

Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia

Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development

Platelet-Derived TGF-β1 Promotes Deep Vein Thrombosis

Inhibition of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation Reduces Angiotensin II-Induced Abdominal Aortic Aneurysm Rupture in Mice

Neutrophil extracellular traps and cancer-associated thrombosis

Lysophosphatidic acid promotes thrombus stability by inducing rapid formation of neutrophil extracellular traps: A new mechanism of thrombosis